| NCT ID | NCT06707519 |
| Status | Recruiting |
| Phase | — |
| Sponsor | St. Joseph's Healthcare Hamilton |
| Condition | Lung Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 210 participants |
| Start Date | 2023-02-01 |
| Primary Completion | 2027-12-29 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 210 participants in total. It began in 2023-02-01 with a primary completion date of 2027-12-29.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of the study is to determine the feasibility of recruiting participants and using sputum, Bronchoalveolar lavage (BAL) and exhaled Volatile Organic Compounds (VOC) in addition to blood, as biological samples for detecting mutations in extracted cell-free DNA in non-small cell lung cancer (NSCLC) patients, before and after surgery, and any recurrence within a 24-month postoperative follow-up period. This is a pilot feasibility study, proposed as a 24-month prospective, single-center, non-interventional, observational trial with NSCLC-adenocarcinoma patients indicated for resection surgery with curative intent.
Eligibility Criteria
Inclusion Criteria: * Patient must be at least 18 years of age * Patient must be able to provide consent * Patients undergoing surgical resection with curative intent for non-small cell lung cancer at St. Joseph's Healthcare Hamilton and Firestone Institute for Respiratory Health. Exclusion Criteria: * Resection done with non-curative intent or metastatic disease * other malignancies * Patients with previously treated malignancy less than 5 years prior to current resection (not including skin cancer).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06707519 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Lung Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06707519 currently recruiting?
Yes, NCT06707519 is actively recruiting participants. Contact the research team at Lhalwagi@stjosham.on.ca for enrollment information.
Where is the NCT06707519 trial being conducted?
This trial is being conducted at Hamilton, Canada.
Who is sponsoring the NCT06707519 clinical trial?
NCT06707519 is sponsored by St. Joseph's Healthcare Hamilton. The trial plans to enroll 210 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.